Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Theranostics
|
August 4, 2025
Comparison of targeting two antigens (GPA33 versus HER2) for <sup>225</sup>Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer
Sara S Rinne, Daniela Burnes Vargas, Brett A Vaughn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2016
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
Neeta Pandit-Taskar, Joseph A O'Donoghue, Shutian Ruan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 5, 2019
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using <sup>89</sup>Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
Jorge A Carrasquillo, Bernard M Fine, Neeta Pandit-Taskar, et al.
Molecular Pharmaceutics
|
May 24, 2019
Pharmacokinetics and Biodistribution of a [<sup>89</sup>Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients
Joseph A O'Donoghue, Daniel C Danila, Neeta Pandit-Taskar, et al.
Theranostics
|
November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
Keifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Molecular Cancer Therapeutics
|
October 20, 2021
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis
Christopher S Chandler, Meghan M Bell, Sebastian K Chung, et al.
Molecular Pharmaceutics
|
May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted Radioimmunodiagnosis
Darren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Theranostics
|
October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative doses
Sarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled Radiohapten
Brett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Theranostics
|
August 4, 2025
Comparison of targeting two antigens (GPA33 versus HER2) for <sup>225</sup>Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer
Sara S Rinne, Daniela Burnes Vargas, Brett A Vaughn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2016
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
Neeta Pandit-Taskar, Joseph A O'Donoghue, Shutian Ruan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 5, 2019
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using <sup>89</sup>Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
Jorge A Carrasquillo, Bernard M Fine, Neeta Pandit-Taskar, et al.
Molecular Pharmaceutics
|
May 24, 2019
Pharmacokinetics and Biodistribution of a [<sup>89</sup>Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients
Joseph A O'Donoghue, Daniel C Danila, Neeta Pandit-Taskar, et al.
Theranostics
|
November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
Keifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Molecular Cancer Therapeutics
|
October 20, 2021
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis
Christopher S Chandler, Meghan M Bell, Sebastian K Chung, et al.
Molecular Pharmaceutics
|
May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted Radioimmunodiagnosis
Darren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Theranostics
|
October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative doses
Sarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled Radiohapten
Brett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 22, 2014
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Volkan Beylergil, et al.
Page
of 8